Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases.

World Allergy Organ J · 2018 · PMC6276141 · PMID 30524647

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Total eosinophil numbers at the diagnosis of EGPA were higher in the non-responder group than in responder patients, although it did not reach statistical significance (5564 ± 5454 cells/mm 3 vs. 3747 ± 2897 cells/mm 3 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.